Foundayo (Orforglipron) Approved in April 2026, Foundayo is the latest in GLP-1 weight loss medications
But more clinical studies are still needed to confirm its efficacy and safety
Endocrinology, 151(4), 1473-1486
In addition, while the company sells compounded GLP-1 drops primarily for weight loss, there is only one comparative FDA-approved GLP-1 drug that is taken orally, a pill that is only approved to treat diabetes
Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703 Disclaimer The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals
Media for Patients Related Conditions June 02, 2026 Guest Speaker Ronald Prussick, M.D., FRCPC Title Vice Chair, Medical Board, National Psoriasis Foundation Dermatologist and Medical Director, Washington Dermatology Center, Rockville and Frederick, MD Guest Speaker Brittany Weber, M.D., Ph.D